New Salk research reveals how the cancer drug entinostat works inside pancreatic cancer cells.
The findings point to new combination treatment strategies and a way to deliver the drug directly to tumors.
www.salk.edu/news-release...
salk.edu
Foundational research points to new therapeutic strategies for an emerging cancer drug - Salk Institute for Biological Studies
Highlights Salk researchers investigated the impacts of entinostat, a drug that targets HDAC proteins, and found it inactivates DNA damage repair genes in pancreatic cancer cells The discovery led to ...